Enterprise Value

-124.4M

Cash

207.2M

Avg Qtr Burn

-19.91M

Short % of Float

2.25%

Insider Ownership

13.73%

Institutional Own.

64.06%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date